NTAGI recommends reducing Covishield dose gap to 8-16 weeks

The National Technical Advisory Group on Immunisation (NTAGI) has recommended reducing the gap of Covid vaccine Covishield to 8 to 16 weeks after 1st dose of vaccine in view of ongoing Omicron pandemic, said a source on Sunday.

Presently, the second dose of Covishield is being administered 12-16 weeks after the first dose under the national vaccination drive. India’s apex body on immunisation NTAGI has recommended this in view of recent surge in the global Covid caseload.

The recommendation is expected to ramp up the administration of the second dose of Covishield to the remaining population amid rising cases in European nations and some other countries.

The government had on May 13, 2021 extended the gap between the first and second doses of the Covishield vaccine from 6-8 weeks to 12-16 weeks based on the recommendations by NTAGI that provides guidance to the Union Health Ministry on the immunisation.

Medlarge

Recent Posts

India committed to be malaria-free by 2030: Health ministry

The latest World Malaria Report 2024, released by the World Health Organization (WHO), has celebrates…

16 hours ago

Centre to provide 30% subsidy on electric ambulances

 The centre is preparing a draft to provide up to 30% subsidy of the cost…

16 hours ago

Why north India faces severe pollution and south lesser level, study explains

Pollution in east, north and central Indian cities primarily comes from residential and transportationsectors, while…

3 days ago

Despite treatment under National Elimination Program, people incur ‘catastrophic’ costs on TB

Despite free tuberculosis diagnosis and treatment under India's National TB Elimination Program, nearly half the…

3 days ago

Myth vs Fact on Constipation: Reminder for often ignored health issue

December marks World Constipation Month, a timely opportunity to address constipation—a commonly overlooked yet widespread…

3 days ago